Treatment outcomes in young adults with gastric cancer
Автор: Pugaev D.M., Ryabov A.B., Khomyakov V.M., Kolobaev I.V., Kostrygin A.K., Aleksandrov O.A., Pogosyan G.S., Sobolev D.D., Chayka A.V., Utkina A.B., Lyubchenko L.N., Kaprin A.D.
Журнал: Сибирский онкологический журнал @siboncoj
Рубрика: Клинические исследования
Статья в выпуске: 6 т.23, 2024 года.
Бесплатный доступ
Introduction. According to global data, gastric cancer (GC) is the 5-th most common malignancy with a high cancer-related mortality rate. However, in recent decades, there has been a tendency towards an increase in the incidence of GC among young patients (18 to 40 years old), which currently amounts to 4.4-9.8%.
Young adults with gastric cancer, multimodal treatment, hyperthermic intraoperative intraperitoneal chemotherapy (hipec), pressurized intraperitoneal aerosol chemotherapy (pipac)
Короткий адрес: https://sciup.org/140308739
IDR: 140308739 | DOI: 10.21294/1814-4861-2024-23-6-7-21
